CTI BIOPHARMA CORP's ticker is CTICXXXX and the CUSIP is 12648L106. A total of 90 filers reported holding CTI BIOPHARMA CORP in Q4 2014. The put-call ratio across all filers is 0.28 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $709,000 | -3.7% | 1,740,491 | -11.5% | 0.00% | 0.0% |
| Q3 2016 | $736,000 | +587.9% | 1,966,847 | +523.3% | 0.00% | – |
| Q2 2016 | $107,000 | +1683.3% | 315,544 | +2486.4% | 0.00% | – |
| Q1 2016 | $6,000 | -99.5% | 12,200 | -97.8% | 0.00% | -100.0% |
| Q2 2015 | $1,094,000 | -21.1% | 561,124 | -4.6% | 0.00% | -33.3% |
| Q4 2014 | $1,387,000 | -43.3% | 587,916 | -41.8% | 0.00% | -57.1% |
| Q3 2014 | $2,446,000 | +25.7% | 1,010,871 | +45.9% | 0.01% | +40.0% |
| Q2 2014 | $1,946,000 | – | 692,650 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DAFNA Capital Management LLC | 1,425,000 | $3,363,000 | 2.66% |
| ACUTA CAPITAL PARTNERS, LLC | 1,228,111 | $2,898,000 | 1.96% |
| Sio Capital Management, LLC | 505,000 | $1,192,000 | 0.94% |
| RA Capital Management | 2,500,000 | $5,900,000 | 0.63% |
| SPHERA FUNDS MANAGEMENT LTD. | 750,000 | $1,770,000 | 0.30% |
| TFS CAPITAL LLC | 1,295,744 | $3,058,000 | 0.29% |
| EAGLE ASSET MANAGEMENT INC | 12,713,051 | $30,002,000 | 0.17% |
| JW Asset Management, LLC | 52,271 | $123,000 | 0.09% |
| Lombard Odier Asset Management (USA) Corp | 501,444 | $1,183,000 | 0.08% |
| First Heartland Consultants, Inc. | 74,624 | $176,000 | 0.07% |